Concierge Cardiology · Chronic Management

Heart Failure Monitoring.

Personalized, physician-led heart failure monitoring with direct access to your cardiology team. Proactive monitoring. Faster interventions. Better outcomes.

Sandeep M. Patel, MD
Sandeep M. Patel, MD, Structural & Interventional Cardiologist
6.7 million Americans living with heart failure (AHA, 2024)
Prevalence
#1 cause of hospitalization in adults over 65
Hospitalization
Fewer than 25% of eligible patients on target GDMT doses nationally
Gdmt Gap
Overview

Understanding heart failure monitoring.

Heart failure affects over 6.7 million Americans, with approximately 1 million new diagnoses each year according to the AHA 2024 Heart Disease and Stroke Statistics. Despite advances in guideline-directed medical therapy (GDMT), heart failure remains the leading cause of hospitalization in adults over 65, costing the U.S. healthcare system more than $43 billion annually. The cornerstone of modern heart failure management — quadruple therapy with ARNI/ACEi, beta-blocker, MRA, and SGLT2 inhibitor — requires careful titration, frequent lab monitoring, and close symptom surveillance. Yet in traditional practice, fewer than 25% of eligible patients are on target doses of all four pillars per the CHAMP-HF registry. Gaps in follow-up and slow up-titration contribute directly to preventable hospitalizations and mortality. Our concierge heart failure program ensures every patient receives fully optimized GDMT, with remote weight and symptom monitoring, proactive diuretic adjustments, and rapid response to early decompensation signals — reducing 30-day readmission rates and improving both survival and functional capacity.

Why Concierge

Why concierge cardiology for this condition.

Heart failure is a condition that demands vigilance between office visits. A 2-pound weight gain overnight, increasing orthopnea, or subtle changes in exercise tolerance can herald decompensation days before a crisis. In traditional care, these warning signs go undetected until they become emergency department visits. Concierge heart failure management provides daily remote weight and symptom monitoring reviewed by your cardiologist, medication titration visits every 2-4 weeks until target GDMT doses are achieved, and immediate physician access when symptoms change. The result is faster GDMT optimization — reaching target doses in 8-12 weeks instead of the 12-18 months typical in community practice — and dramatic reductions in hospitalization. Studies of remote monitoring programs similar to ours show 30-50% reductions in heart failure readmissions.

What we monitor.

Daily weight trends and fluid balance via connected smart scales
NYHA functional class progression and 6-minute walk distance
NT-proBNP or BNP levels every 4-8 weeks during GDMT optimization
Renal function (BMP) and potassium levels with each medication adjustment
Echocardiographic parameters: LVEF, LV volumes, GLS, diastolic function, and RVSP
Implantable device data (ICD/CRT) including thoracic impedance and arrhythmia burden
Iron studies and hemoglobin for IV iron candidacy per 2022 AHA/ACC/HFSA guidelines

Our management approach.

Rapid GDMT optimization: sacubitril-valsartan, beta-blocker, MRA, and SGLT2 inhibitor titrated to target doses within 12 weeks
Daily remote monitoring with smart scales and symptom questionnaires reviewed by your care team
Proactive diuretic adjustment protocols — patients can adjust furosemide doses based on weight thresholds with physician oversight
Iron deficiency screening and IV iron infusion coordination (ferritin < 100 or 100-299 with TSAT < 20%)
Advanced therapy evaluation: CRT, LVAD, and transplant referral when appropriate
Cardiac rehabilitation enrollment and supervised exercise training per HF-ACTION trial protocols
Sodium restriction (< 1500 mg/day), fluid management, and nutritional counseling

Expected outcomes.

30-50% reduction in heart failure hospitalizations through early decompensation detection (TIM-HF2 trial data)
GDMT optimization to target doses in 85%+ of patients (vs. < 25% nationally per CHAMP-HF registry)
Improvement in LVEF by 5-15% in HFrEF patients within 6-12 months of optimized therapy
Improved exercise capacity: average 40-60 meter improvement in 6-minute walk distance
Meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ) quality-of-life scores

Related concierge services.

Hypertension Management
Atrial Fibrillation Management
Arrhythmia Monitoring & Device Management

Optimize your heart failure treatment with proactive concierge monitoring and expert GDMT management.

Direct physician access, proactive monitoring, and personalized care plans. Concierge cardiology starting at $295/month.

View Concierge Plans About Concierge Cardiology